Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2) is a genetic element classified as a pseudogene and is not believed to encode a functional protein. It is named for its homology to the active gene cysteinyl-tRNA synthetase 1 (CARS1), which catalyzes the attachment of cysteine to its corresponding tRNA during protein synthesis, but CARS1P2 itself lacks coding potential and no biological, pathological, or therapeutic roles have been reported[1][5][6]. Context and supporting details: - CARS1P2 is distinct from CARS1 (also known as cysteinyl-tRNA synthetase 1), which is a functional enzyme involved in protein biosynthesis and associated with various human diseases[4][7]. - No evidence in the scientific or medical literature supports CARS1P2 as a therapeutic target, receptor, enzyme, or drug-interacting protein[1][5][6]. - Pseudogenes such as CARS1P2 do not generally produce functional proteins or have direct biological functions but may occasionally have regulatory roles; no such roles are documented for this locus[1][5][6]. - Relevant biomedical databases classify CARS1P2 strictly as a pseudogene, and no published studies link it to disease, drug interactions, or biomarker utility[1][5][6]. Summary: CARS1P2 is a noncoding pseudogene with no direct functional, therapeutic, or diagnostic relevance. It should not be considered a molecular target, and there are no known roles in health or disease. If you intended to inquire about the active enzyme cysteinyl-tRNA synthetase 1 (CARS1), please specify[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteinyl-tRNA synthetase 1 pseudogene 2 (CARS1P2).